a.reyes
TL4 Administrator Co-founder · Governance · Lisbon, PT
Co-founded The Peptide Commons in May 2024 to see whether a peptide community could be run in the open. I write and maintain the guidelines, publish the moderation log, and answer anything about how this place is governed. I am not a clinician and I do not give dosing advice.
Joined 18 May 2024 · last posted 21h · groups: staff, moderators, wiki-editors, trust-level-4
235 posts, newest first. Showing up to 150.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #100 · Access › Insurance & coverage · 27 Jul 2026 · 3 likes Everything in post #98 holds. The case it does not cover is the one I have. Date every account in this subcategory. Payer criteria change frequently and the archive…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #27 · Analytics › COA interpretation · 27 Jul 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #29 · Compounds › Oral incretins · 26 Jul 2026 · 20 likes Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
-
Seven-day rolling means and why weekly readings mislead Replied, post #94 · Outcomes › Progress reports · 23 Jul 2026 · 5 likes On post #92 — agreed on the reasoning, with one qualification. I would keep seven-day rolling and the decision it usually gets used for separate in this thread. They…
-
How shortages have affected compounding permissions Replied, post #62 · Access › Shortages · 23 Jul 2026 · 12 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Priming a pen and whether the primed volume is wasted Replied, post #19 · Devices › Pens & autoinjectors · 23 Jul 2026 · 2 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #50 · Compounds › Secretagogues & GH axis · 23 Jul 2026 · 10 likes This settles it for me, at least until somebody posts a reason it should not.
-
Request: a per-category review queue Replied, post #120 · Meta › Feature requests · 21 Jul 2026 · 0 likes Post #117 is right about the mechanism and I think understates the practical bit. That is exactly the objection, and it is not a refusal on principle. Anything the site…
-
Seven-day rolling means and why weekly readings mislead Replied, post #75 · Outcomes › Progress reports · 21 Jul 2026 · 3 likes Offering a way to settle seven-day rolling rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #28 · Sourcing › Vendor reports · 20 Jul 2026 · 0 likes On Reconciling a supplier certificate, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the…
-
Which categories are strict and which are relaxed, honestly Replied, post #26 · Start Here › Welcome · 18 Jul 2026 · 26 likes Welcome. Two practical notes from staff. Your first few posts are rate-limited, which is an anti-spam measure and not a comment on you, and it lifts on its own. If you…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #16 · Analytics › COA interpretation · 17 Jul 2026 · 18 likes Narrowing post #15, because the general version has more than one answer. Checked the Batch date claim against the primary source this morning. It survives, with a…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #6 · Compounds › Repair & healing peptides · 15 Jul 2026 · 4 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #21 · Practice › Side effects · 14 Jul 2026 · 18 likes The practical division worth making is between symptoms that are unpleasant, symptoms that are limiting, and symptoms that are a reason to stop and get assessed. They…
-
Which categories are strict and which are relaxed, honestly Replied, post #8 · Start Here › Welcome · 12 Jul 2026 · 5 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
How much context is too much context in a first post? Replied, post #68 · Start Here › How to Ask · 10 Jul 2026 · 9 likes Staff note on titles, since it comes up. We retitle topics fairly often, always leaving the original in the first post and always logging it. It is not a criticism of…
-
Submitting a sample: the process end to end Replied, post #63 · Sourcing › Independent verification · 6 Jul 2026 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. The step people skip is the one I have…
-
Forced degradation studies: designing one that is informative Replied, post #91 · Analytics › Method validation · 5 Jul 2026 · 1 like I had written a reply contradicting post #89 and deleted it. Here is what survived. Transfer between laboratories: a method can be transferred from one lab to another,…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #79 · Compounds › Semaglutide · 26 Jun 2026 · 1 like Something worth flagging about semaglutide and gastric emptying: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #15 · Compounds › Retatrutide · 24 Jun 2026 · 14 likes Comparisons with tirzepatide are being made across trials rather than within one. Different populations, different durations, different endpoints; the effect sizes are…
-
[2026 update] Correlation in a self-tracked dataset: what it can support Replied, post #2 · Research Methods › Statistics · 21 Jun 2026 · 0 likes Checked the Correlation claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
Request: a per-category review queue Replied, post #48 · Meta › Feature requests · 20 Jun 2026 · 2 likes Staff view: this is a good request and a larger one than it looks, because the citation is currently a link rather than a relationship. Recording it properly is the…
-
Coming back to: How much context is too much context in a first post? Replied, post #5 · Start Here › How to Ask · 18 Jun 2026 · 0 likes Staff note on titles, since it comes up. We retitle topics fairly often, always leaving the original in the first post and always logging it. It is not a criticism of…
-
Follow-up: Search filters: what is missing Replied, post #131 · Meta › Site feedback · 17 Jun 2026 · 0 likes That distinction is real and staff have discussed it twice without deciding. The risk is that a topic marked unanswered discourages the reply that would answer it. If…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #7 · Start Here › How to Ask · 13 Jun 2026 · 6 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. Staff note on titles, since it comes up. We retitle topics fairly…
-
What I would want from a home test that does not exist yet Replied, post #9 · Analytics › Home & field testing · 12 Jun 2026 · 11 likes Photographs of test results posted here are worth including with the lighting and the timing stated, because both change the apparent result of a colorimetric method…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #93 · Outcomes › Body composition · 11 Jun 2026 · 20 likes Everything in post #91 holds. The case it does not cover is the one I have. Neither method is capable of detecting the month-to-month changes that people report…
-
A checklist for reading a certificate in under two minutes Replied, post #38 · Analytics › COA interpretation · 11 Jun 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Racemisation and why it is invisible to a mass measurement Replied, post #13 · Analytics › Impurities & related substances · 8 Jun 2026 · 2 likes Racemisation is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Revisiting: Mobile reading experience on long topics Replied, post #9 · Meta › Site feedback · 8 Jun 2026 · 4 likes Building on post #8 rather than restating it. Both noted and both reasonable. Staff will not promise a date — everybody here is a volunteer and the queue is long — but…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #20 · Pharmacology › Pharmacokinetics · 8 Jun 2026 · 0 likes The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the concentration after several doses is roughly double the…
-
Follow-up: Search filters: what is missing Replied, post #122 · Meta › Site feedback · 7 Jun 2026 · 15 likes Logged, and thank you for the precise description. That is a wording problem rather than a logic problem — an empty state that says "no topics match both filters" is a…
-
Bioimpedance and hydration: why the number moves Replied, post #56 · Outcomes › Body composition · 6 Jun 2026 · 0 likes Report the method with the number, always. A composition figure without the method is not comparable to anything, including your own previous figure. Genuinely open to…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #82 · Sourcing › Red flags · 6 Jun 2026 · 16 likes Post #79 answers the question as asked. The question underneath it is different. Where I have landed on certificate whose chromatogram axes, having got it wrong once in…
-
What a certificate commits its issuer to — one year on Replied, post #82 · Analytics › COA interpretation · 5 Jun 2026 · 17 likes Check the lot on the vial against the lot on the document before anything else. It is the cheapest check available and it is the one that catches the mismatches that…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #54 · Access › Insurance & coverage · 5 Jun 2026 · 0 likes Everything in post #50 holds. The case it does not cover is the one I have. Something worth flagging about appeal: the strongest-sounding claims in this thread are the…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #40 · Practice › Storage & stability · 4 Jun 2026 · 0 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Revisiting: The best-written scientific paper you have read Replied, post #13 · Lounge › Off topic · 3 Jun 2026 · 3 likes Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does. That is what I…
-
Publication patterns in the BPC-157 literature, examined Replied, post #6 · marked as the solution · Compounds › Repair & healing peptides · 2 Jun 2026 · 11 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #34 · Compounds › Repair & healing peptides · 31 May 2026 · 0 likes Worth stating the null on absence of controlled human data before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does…
-
CJC-1295 with and without DAC: what the modification does Replied, post #68 · Compounds › Secretagogues & GH axis · 27 May 2026 · 9 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #24 · Clinical › Special populations · 25 May 2026 · 30 likes I read post #21 twice before replying, because I had assumed the opposite. Nothing in this subcategory is medical advice and the questions asked here are precisely the…
-
Moderation log format change Replied, post #54 · Meta › Announcements · 19 May 2026 · 8 likes The most useful thing anyone has posted about moderation log format change in this category was a table of what had been measured and by whom. That is what I would want…
-
Tracking a shortage from primary sources rather than rumour Replied, post #5 · Access › Shortages · 10 May 2026 · 2 likes Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be opposite. The disagreement above is smaller than it…
-
Search filters: what is missing Replied, post #55 · Meta › Site feedback · 8 May 2026 · 0 likes Staff answer. The behaviour described is intended, and the reasoning is that the alternative failed in a specific way we watched happen. Happy to be argued out of it,…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #24 · Analytics › Home & field testing · 8 May 2026 · 10 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #43 · Evidence › Journal club · 7 May 2026 · 0 likes This follows post #42 rather than contradicting it. The honest answer on SURMOUNT-1 is that it depends, and the useful part is the list of what it depends on. Four…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #42 · Meta › Announcements · 6 May 2026 · 33 likes Coming back to post #40, because the follow-up matters more than the original answer. The edit is clearer. For anyone arriving now, read the edited version — the…
-
Request declined, with reasoning — what changed since Replied, post #36 · Meta › Feature requests · 5 May 2026 · 26 likes Taking post #35 at face value and following it one step further. That reframing is better than the original request and staff would consider it. Which is a good…
-
Request: show the solution author in the topic list — what changed since Replied, post #91 · Meta › Feature requests · 4 May 2026 · 2 likes Confirming post #88 from a second method, which matters more than confirming it from a second person. That is exactly the objection, and it is not a refusal on…
-
Historical amylin analogues and what happened to them Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 4 May 2026 · 16 likes Building on post #4 rather than restating it. What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with…
-
Request: show the solution author in the topic list — what changed since Replied, post #75 · Meta › Feature requests · 3 May 2026 · 5 likes Adding the measurement that post #74 says would settle it. Staff view: this is a good request and a larger one than it looks, because the citation is currently a link…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #4 · Compounds › Retatrutide · 2 May 2026 · 3 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #9 · Sourcing › Independent verification · 2 May 2026 · 11 likes Adding the measurement that post #6 says would settle it. Trying to state the Janoshik position in a way that someone who disagrees would recognise as fair, because I…
-
Request: show the solution author in the topic list — what changed since Replied, post #35 · Meta › Feature requests · 2 May 2026 · 1 like The arithmetic in post #34 is right; the assumption feeding it is the part to check. Both of these are in the same family and staff would rather do one thing well than…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #19 · Analytics › Home & field testing · 29 Apr 2026 · 26 likes Sensible. I would want the same detail before I acted on it either.
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Started this topic · Documentation › Doc review · 28 Apr 2026 · 10 likes Posting this under the heading it deserves: Review: a draft on reconstitution arithmetic, with objections — what changed since Everything below is what sits behind…
-
Electrolyte supplements: which ones do anything Started this topic · Nutrition & Training › Hydration & electrolytes · 27 Apr 2026 · 6 likes On the subject in the title: Electrolyte supplements: which ones do anything Working notes rather than a conclusion. A hydration and intake question, with the figures,…
-
Prescription portability between countries Replied, post #15 · Access › International · 24 Apr 2026 · 0 likes Post #12 is the version of this I will quote in future. One addition. Regional practice around what a pharmacy will and will not do varies enormously and is not…
-
Blinding yourself: practical methods and their limits Replied, post #20 · Research Methods › N-of-1 designs · 23 Apr 2026 · 9 likes Where I would push back on the blinding yourself consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Why the timeline is on the right and not the left — what changed since Replied, post #24 · Meta › Site feedback · 22 Apr 2026 · 5 likes The arithmetic in post #21 is right; the assumption feeding it is the part to check. The strongest argument against my own position on timeline, stated as well as I can…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #43 · Devices › Syringes & needles · 19 Apr 2026 · 33 likes Picking up post #42: that is the part I would want checked first. One more thing on 0.3 ml versus 0.5 ml that took me far too long to see: the two figures people quote…
-
CJC-1295 with and without DAC: what the modification does Replied, post #37 · Compounds › Secretagogues & GH axis · 19 Apr 2026 · 13 likes A purity figure without a method for a short peptide is nearly uninterpretable, because short peptides can be run on gradients that resolve almost nothing and still…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #115 · Clinical › Special populations · 18 Apr 2026 · 2 likes Picking up post #112: that is the part I would want checked first. Post-surgical populations, particularly after procedures affecting the gastrointestinal tract,…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #85 · Compounds › Tirzepatide · 16 Apr 2026 · 5 likes 2.5 mg starting dose is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
-
Prescription portability between countries Replied, post #9 · Access › International · 16 Apr 2026 · 28 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. Speaking only to prescription portability between countries as I have actually seen…
-
Request: export my own posts — one year on Replied, post #71 · Meta › Feature requests · 10 Apr 2026 · 0 likes Taking post #69 at face value and following it one step further. That reframing is better than the original request and staff would consider it. Which is a good…
-
Spike-and-recover accuracy for a peptide assay Replied, post #29 · Analytics › Method validation · 7 Apr 2026 · 0 likes The most useful reply I ever got about spike-and-recover accuracy was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Bioimpedance and hydration: why the number moves Replied, post #27 · Outcomes › Body composition · 6 Apr 2026 · 1 like Checked the bioimpedance and hydration claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #32 · Outcomes › Body composition · 6 Apr 2026 · 6 likes This follows post #31 rather than contradicting it. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to standardise.…
-
The "under review" status pill and when a moderator applies it Replied, post #39 · Evidence › Preprints · 26 Mar 2026 · 14 likes Post #37 put the caveat in the right place and I want to underline it. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint].…
-
Journal club: is percentage weight change the right endpoint? Replied, post #15 · Evidence › Journal club · 26 Mar 2026 · 1 like Picking up post #14: that is the part I would want checked first. The most common failure mode is spending fifty minutes on the effect size and ten on the population.…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #80 · Compounds › Semaglutide · 19 Mar 2026 · 30 likes On post #76 — agreed on the reasoning, with one qualification. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people…
-
Why this subcategory is stricter about sourcing than most Replied, post #9 · Compounds › Secretagogues & GH axis · 18 Mar 2026 · 10 likes Marking my place. If it changes for me I will come back and say so.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #6 · Clinical › Comorbidities · 13 Mar 2026 · 16 likes The version of PCOS and metabolic overlap that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #27 · Lounge › Introductions · 10 Mar 2026 · 2 likes Clinician voices are genuinely welcome and are asked to be explicit about the line. Several members here say plainly in every post that they are describing general…
-
The lowest dose that does anything: is that a real question? Replied, post #111 · Practice › Dosing & titration · 8 Mar 2026 · 30 likes Taking post #109 at face value and following it one step further. The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #13 · Practice › Dosing & titration · 7 Mar 2026 · 13 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 3 Mar 2026 · 0 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #101 · Access › Pricing · 27 Feb 2026 · 1 like Second-hand on Price changes, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #33 · Practice › Interactions · 26 Feb 2026 · 5 likes Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #48 · Analytics › Mass spectrometry · 24 Feb 2026 · 23 likes I had written a reply contradicting post #44 and deleted it. Here is what survived. If you are new and reading this thread for the answer to Adducts: the answer is…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #134 · Practice › Dosing & titration · 22 Feb 2026 · 0 likes Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #76 · Clinical › Bloodwork · 14 Feb 2026 · 4 likes Narrowing post #73, because the general version has more than one answer. Adding a reference point for panel. Mine is a single case, collected without controls, and I…
-
Amylin receptor signalling and satiety — what changed since Replied, post #29 · Pharmacology › Receptor biology · 12 Feb 2026 · 1 like Post #28 is right about the mechanism and I think understates the practical bit. Nothing in receptor biology tells you what is in the vial, which is worth remembering…
-
Trifluoroacetate content and its consequences Replied, post #82 · Analytics › Impurities & related substances · 4 Feb 2026 · 0 likes Narrowing post #81, because the general version has more than one answer. I would keep trifluoroacetate content and the decision it usually gets used for separate in…
-
Waist circumference technique and its repeatability Replied, post #46 · Outcomes › Progress reports · 2 Feb 2026 · 23 likes Worth stating the null on waist circumference technique before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not…
-
Managing an unplanned gap in supply Replied, post #15 · Access › Shortages · 27 Jan 2026 · 3 likes Adding the measurement that post #12 says would settle it. My experience of managing an unplanned gap contradicts the reply above. I am posting it as a data point…
-
MHRA statements, read directly Replied, post #76 · Regional › UK & Ireland · 26 Jan 2026 · 0 likes Everything in post #74 holds. The case it does not cover is the one I have. I disagree with the framing of MHRA statements above, and I think it is a substantive…
-
Request: export my own posts — one year on Replied, post #38 · Meta › Feature requests · 25 Jan 2026 · 1 like The confident answers on export and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Personal import allowances, compared — a second dataset Replied, post #56 · Access › International · 22 Jan 2026 · 14 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #11 · Practice › Administration · 21 Jan 2026 · 15 likes I read post #7 twice before replying, because I had assumed the opposite. A genuinely late dose: the labelling generally says that if the next dose is more than a…
-
Guidelines revision: what changed and why — does this still hold? Replied, post #3 · Meta › Announcements · 10 Jan 2026 · 31 likes Announcement about the vendor documentation set. Two pages have had their review dates brought forward because the underlying records changed. The pages themselves say…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #35 · Outcomes › Body composition · 3 Jan 2026 · 1 like Lean mass in these measurements includes water, so a change in hydration appears as a change in lean mass. I am reporting what happened, not recommending it.
-
Coverage in the US: a map of the usual obstacles Replied, post #30 · Regional › North America · 1 Jan 2026 · 0 likes Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do.
-
Request: a diff view for wiki revisions — the long version Replied, post #92 · Meta › Feature requests · 31 Dec 2025 · 20 likes Staff view: this is a good request and a larger one than it looks, because the citation is currently a link rather than a relationship. Recording it properly is the…
-
Reading an interaction checker output critically Replied, post #74 · Practice › Interactions · 24 Dec 2025 · 0 likes Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an…
-
Guidelines revision: what changed and why — one year on Replied, post #47 · Meta › Announcements · 16 Dec 2025 · 0 likes Announcement about the vendor documentation set. Two pages have had their review dates brought forward because the underlying records changed. The pages themselves say…
-
Request: a diff view for wiki revisions — the long version Replied, post #81 · Meta › Feature requests · 8 Dec 2025 · 0 likes That reframing is better than the original request and staff would consider it. Which is a good illustration of why these belong in public: the first version would have…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #21 · Clinical › Bloodwork · 2 Dec 2025 · 0 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. Panel came up in a thread eighteen months ago and was answered well. I cannot find…
-
A parcel stationary at a customs facility for nine days Replied, post #7 · Sourcing › Logistics · 24 Nov 2025 · 31 likes Post #6 is the version of this I will quote in future. One addition. Border outcomes are not predictable at the level of an individual parcel. What is predictable is…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #135 · Start Here › How to Ask · 24 Nov 2025 · 17 likes Helpful, and short, which on this subject is harder than long.
-
Reading SURMOUNT-1 without the press release Replied, post #75 · Compounds › Tirzepatide · 22 Nov 2025 · 11 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #26 · Practice › Storage & stability · 22 Nov 2025 · 7 likes Post #23 answers the question as asked. The question underneath it is different. The two questions that get merged here are whether material is degraded and whether it…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #42 · Sourcing › Regulatory · 21 Nov 2025 · 24 likes Answering the question post #38 raises rather than the one it answers. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is…
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #4 · Practice › Side effects · 21 Nov 2025 · 24 likes Everything in the opening post holds. The case it does not cover is the one I have. Agreed on Injection-site reactions, with one qualification that I think matters. The…
-
Availability by country, dated, with primary sources Replied, post #65 · Access › International · 18 Nov 2025 · 6 likes Thank you for the correction. I would rather find out here than later.
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #10 · Start Here › Welcome · 9 Nov 2025 · 29 likes Welcome. Two practical notes from staff. Your first few posts are rate-limited, which is an anti-spam measure and not a comment on you, and it lifts on its own. If you…
-
Reading an interaction checker output critically Replied, post #38 · Practice › Interactions · 7 Nov 2025 · 21 likes Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #15 · Sourcing › Regulatory · 4 Nov 2025 · 4 likes An observation about Pharmaceutical compounding rules that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public…
-
A comparison of home results against a laboratory result on the same vial Replied, post #58 · Analytics › Home & field testing · 4 Nov 2025 · 2 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #61 · Pharmacology › Receptor biology · 3 Nov 2025 · 2 likes Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #27 · Start Here › How to Ask · 28 Oct 2025 · 8 likes Post #23 describes the usual case. This is about the unusual one. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #78 · Sourcing › Vendor reports · 23 Oct 2025 · 3 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
A 40-week log with the measurement method stated Replied, post #40 · Outcomes › Progress reports · 20 Oct 2025 · 20 likes Fair, and the limits you put on it are the part I will remember.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #5 · Start Here › How to Ask · 17 Oct 2025 · 18 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #30 · Start Here › Welcome · 15 Oct 2025 · 1 like Welcome. Two practical notes from staff. Your first few posts are rate-limited, which is an anti-spam measure and not a comment on you, and it lifts on its own. If you…
-
When to stop reading forums, including this one Replied, post #36 · Wellbeing › Mental health · 13 Oct 2025 · 1 like Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
New subcategory: rationale and scope Replied, post #14 · Meta › Announcements · 13 Oct 2025 · 0 likes Housekeeping announcement. The documentation set has a new maintainer for two pages whose previous maintainer has stepped back after two years. Both pages have been…
-
An orphaned page with no inbound links — the long version Replied, post #3 · Meta › Wiki maintenance · 7 Oct 2025 · 2 likes Agreed and changed to six-monthly. The mechanism is deliberately dull: a page nobody reads can wait, a page everybody reads cannot, and read counts are the only input…
-
Meeting a protein target on a suppressed appetite Replied, post #26 · Nutrition & Training › Protein & intake · 5 Oct 2025 · 2 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #49 · Evidence › Preprints · 29 Sep 2025 · 5 likes Version numbers on a preprint server matter. Citing version one of something now on version four is citing a document that has been superseded by its own authors. It is…
-
Payment method and the leverage it gives you, ranked Replied, post #63 · Sourcing › Payments · 23 Sep 2025 · 15 likes Practical experience of payment method, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #56 · Start Here › How to Ask · 19 Sep 2025 · 0 likes Adding the measurement that post #54 says would settle it. Staff note on titles, since it comes up. We retitle topics fairly often, always leaving the original in the…
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #2 · Compounds › Tirzepatide · 15 Sep 2025 · 3 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Severe abdominal pain: why this is not a forum question — one year on Started this topic · Safety › Adverse events · 10 Sep 2025 · 31 likes Severe abdominal pain: why this is not a forum question — one year on — setting out what I have, and where I think it stops being reliable. A narrow question about…
-
Hypertension improvement and when medication needs revisiting Replied, post #52 · Clinical › Comorbidities · 10 Sep 2025 · 0 likes I had written a reply contradicting post #48 and deleted it. Here is what survived. The version of hypertension improvement that circulates here is a simplification of…
-
Risk-of-bias tools and the judgement they conceal Replied, post #13 · Evidence › Meta-analyses · 5 Sep 2025 · 9 likes Post #10 answers the question as asked. The question underneath it is different. Double extraction with disagreement resolution is standard and is worth checking for,…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #33 · Compounds › Oral incretins · 31 Aug 2025 · 2 likes On analysis of a small molecule: purity by chromatography against a reference standard, identity by mass and by spectroscopy, and residual solvents by a headspace…
-
Confounding by indication, explained with a concrete example Replied, post #2 · Evidence › Study critique · 30 Aug 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #31 · Compounds › Tirzepatide · 29 Aug 2025 · 16 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 25 Aug 2025 · 0 likes The pharmacokinetics support weekly dosing comfortably. What the pharmacokinetics do not tell you is the tolerable escalation rate, and that is the practical constraint…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #28 · Analytics › Mass spectrometry · 14 Aug 2025 · 0 likes Narrowing post #27, because the general version has more than one answer. Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #2 · Evidence › Preprints · 9 Aug 2025 · 15 likes If you cite a preprint in a maintained document here, the convention is to label it in the sentence and to note the check date. The document review will catch the update.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #80 · Compounds › Cagrilintide & amylin analogues · 8 Aug 2025 · 25 likes Combination products complicate the certificate question considerably. Two active components mean two purity determinations and a ratio, and a single figure for a…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #22 · Practice › Storage & stability · 7 Aug 2025 · 29 likes Freeze-thaw is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
A ten-fold dose error caught before injection — one year on Replied, post #149 · Devices › Syringes & needles · 5 Aug 2025 · 22 likes Drawing through a wider needle and injecting through a thinner one is a reasonable approach for a viscous preparation and pointless for an aqueous one. That is my…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #17 · Practice › Storage & stability · 31 Jul 2025 · 2 likes An observation about Freeze-thaw that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #24 · Compounds › Secretagogues & GH axis · 31 Jul 2025 · 0 likes Building on post #23 rather than restating it. A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a…
-
Reading a denial letter as a specification for your appeal Replied, post #3 · Access › Insurance & coverage · 26 Jul 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. A clinician's supporting letter that addresses the criteria explicitly is…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #147 · Devices › Cold chain · 21 Jul 2025 · 0 likes Marking my place. If it changes for me I will come back and say so.
-
About the Administration category Replied, post #5 · Practice › Administration · 17 Jul 2025 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #137 · Compounds › Tirzepatide · 15 Jul 2025 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Sequence verification for an obscure compound: how it is done Replied, post #84 · Compounds › Other compounds · 6 Jul 2025 · 3 likes Building on post #83 rather than restating it. Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound…
-
A supplier that answers analytical questions with restated claims Replied, post #111 · Sourcing › Red flags · 5 Jul 2025 · 0 likes Marking my place. If it changes for me I will come back and say so.
-
Sodium, potassium and magnesium when intake drops Replied, post #40 · Nutrition & Training › Hydration & electrolytes · 2 Jul 2025 · 23 likes Magnesium supplementation is widely recommended in this space with very little supporting evidence for the indications it is recommended for.
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #20 · Data & Tools › Datasets · 1 Jul 2025 · 5 likes This follows post #19 rather than contradicting it. A codebook describing each field takes twenty minutes and is what makes the file usable by anyone but you. Most…
-
AOD-9604 and the fragment hypothesis, revisited Started this topic · Compounds › Other compounds · 20 Jun 2025 · 0 likes Posting this under the heading it deserves: AOD-9604 and the fragment hypothesis, revisited Everything below is what sits behind that. Reading back through what has…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #118 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 32 likes That is the distinction I keep failing to hold on to. Written down now.
-
Half-life, steady state, and accumulation worked through Replied, post #126 · Pharmacology › Pharmacokinetics · 16 Jun 2025 · 26 likes This settles it for me, at least until somebody posts a reason it should not.